Helen Davis

With $82M in funding and novel gene insertion technology, Averna Therapeutics is poised to make waves at the pivotal J.P. Morgan Healthcare Conference.

With a new board chair, regulatory backing, and an AI platform, GC Therapeutics is targeting MS and diabetes with next-generation cell therapies.

As PagerDuty prepares for the Needham conference, it must convince investors its advanced AI can overcome slowing revenue and justify its market leadership.

Daniel Energy Partners appoints Sean Mitchell as CEO and hires veteran analyst Jeff Dietert, doubling down on traditional energy with enhanced research.

Collegium Pharmaceutical projects robust 2026 revenue fueled by its ADHD drug Jornay PM, savvy debt refinancing, and a proactive generic strategy.

CN Energy's robotics arm, Pathenbot, just won a key "Investment-Ready" award at CES 2026. What does this reveal about its disruptive tech and global plans?

Fresh off a CES 2026 Innovation Award win, ULS Robotics' new VIATRIX™ exoskeleton promises to bring industrial-strength assistance to everyday adventurers.

Amid rising virtualization costs, Arcfra's partnership with Netfos introduces a new, AI-ready cloud alternative for Taiwan's tech-driven enterprises.

As legacy brand Hamilton Beach heads to a major conference, its high-stakes pivot from kitchen gadgets to health tech will be under the microscope.

A new partnership bypasses PBMs to offer employers cost-effective obesity drugs paired with comprehensive digital care, aiming to reshape health benefits.

IronCircle's AI training programs now offer a path to a college degree, promising to solve the cyber talent gap. But the road has its own set of challenges.

Making its CES 2026 debut, NuPhy unveils a keyboard lineup that blends elite gaming tech with creative design, aiming to prove work tools can be inspiring.

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

A new nationwide study reveals a massive gap in care for heart failure patients, costing lives and billions. Why are proven, cheap medications being overlooked?

MuniNet partners with Ekinops to deploy next-gen 400G technology, promising a new era of high-speed connectivity and innovation for rural communities.

Blink now accepts crypto at its EV chargers, a strategic move to attract younger drivers. But what does this mean for the industry and for you?

EdgeCortix's SAKURA-II processor survives brutal radiation tests, paving the way for intelligent, real-time decision-making on satellites and the Moon.

With a top neurologist at the helm and a breakthrough platform, NanoMosaic aims to decentralize brain health diagnostics and reshape drug development.

Lazard Asset Management creates a new CIO role, appointing Eric Van Nostrand to unify its global investment platform amid fierce industry competition.

With new CEO Libby Morgan, media agency NOVUS pivots from hyperlocal buyer to a full-funnel growth partner, signaling a major industry shift.